{"abstract": "The settlement by Merck of a shareholder lawsuit over Vioxx represent what may turn out to be a pivotal moment in the corporate governance arena.", "web_url": "https://dealbook.nytimes.com/2010/04/04/does-merck-agreement-pave-a-road-toward-change/", "snippet": "The settlement by Merck of a shareholder lawsuit over Vioxx represent what may turn out to be a pivotal moment in the corporate governance arena.", "lead_paragraph": "Shareholders of Merck sued in 2004, contending that current and former company officers and directors had breached their fiduciary duties in the marketing of the painkiller Vioxx, causing investors to lose billions.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Does Merck Agreement Pave a Road Toward Change?", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Boards of Directors", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Executives and Management", "rank": 3, "major": "N"}, {"name": "subject", "value": "Stocks and Bonds", "rank": 4, "major": "N"}, {"name": "subject", "value": "Suits and Litigation", "rank": 5, "major": "N"}, {"name": "subject", "value": "Vioxx (Drug)", "rank": 6, "major": "N"}], "pub_date": "2010-04-04T18:27:39+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/7a0fba06-b7c0-51ed-9bd4-f0cd0a60d541", "word_count": 1145, "uri": "nyt://article/7a0fba06-b7c0-51ed-9bd4-f0cd0a60d541"}